Disease The intractable diseases designated by MHLW, Japan
Diseases : 338 - Clinical trials : 34,520 / Drugs : 19,957 - ( DrugBank : 2,195 ) / Drug target genes : 613 - Drug target pathways : 297
ID | Disease name [Group] | Clinical trial Phase 1 / 2 / 3 / 4 | Drug [ DrugBank ] | Target gene Target pathway | Domestic patients Med expenses recipients (FY2022) |
---|---|---|---|---|---|
102 | Rubinstein-Taybi syndrome [Chr] 💬 "RSTS", "Histone acetylation disorder" | 3 3 trials | 0 / 2 / 0 / 0 💬 | 5 5 drugs [ 1 1 drug ] | 7 7 genes 17 pathways | 7 7 patientsAge distribution💬 |
103 | Cardio-facio-cutaneous syndrome [Chr] 💬 "CFC syndrome" | 0 - | 0 - | 0 - | 8 8 patientsAge distribution💬 |
104 | Costello syndrome [Chr] 💬 | 0 - | 0 - | 0 - | 9 9 patientsAge distribution💬 |
105 | CHARGE syndrome [Chr] 💬 | 0 - | 0 - | 0 - | 34 34 patientsAge distribution💬 |
165 | Pachydermoperiostosis [Chr] 💬 "PDP", "Early type pachydermoperiostosis", "Early type PDP", "Incomplete type pachydermoperiostosis", "Incomplete type PDP", "Complete type pachydermoperiostosis", "Complete type PDP" | 0 - | 0 - | 0 - | 19 19 patientsAge distribution💬 |
168 | Ehlers-Danlos syndrome [Chr] 💬 "EDS", "Classic EDS", "Classical EDS", "cEDS", "Hypermobile Ehlers-Danlos syndrome", "Hypermobile EDS", "hEDS", "Classical-like Ehlers-Danlos syndrome", "Classical-like EDS", "clEDS", "Vascular Ehlers-Danlos syndrome", "Vascular EDS", "vEDS", "Kyphoscoliosis Ehlers-Danlos syndrome", "Kyphoscoliosis EDS", "kEDS", "Arthrochalasia Ehlers-Danlos syndrome", "Arthrochalasia EDS", "aEDS", "Dermatosparaxis Ehlers-Danlos syndrome", "Dermatosparaxis EDS", "dEDS", "D4ST1-deficient Ehlers-Danlos syndrome", "Dermatan 4-0-sulfotransferase 1-deficient EDS", "D4ST1-deficient EDS", "DDEDS" | 13 13 trials | 1 / 2 / 5 / 3 💬 | 21 21 drugs [ 11 11 drugs ] | 11 11 genes 103 pathways | 217 217 patientsAge distribution💬 |
170 | Occipital horn syndrome [Chr] 💬 | 2 2 trials | 1 / 1 / 1 / 0 💬 | 4 4 drugs [ 3 3 drugs ] | 9 9 genes 14 pathways | 2 2 patientsAge distribution💬 |
173 | VATER syndrome [Chr] 💬 "VATER association", "VACTERL association" | 0 - | 0 - | 0 - | 14 14 patientsAge distribution💬 |
174 | Nasu-Hakola disease [Chr] 💬 "Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy", "PLOSL" | 0 - | 0 - | 0 - | 6 6 patientsAge distribution💬 |
175 | Weaver syndrome [Chr] 💬 | 0 - | 0 - | 0 - | - |
176 | Coffin-Lowry syndrome [Chr] 💬 | 0 - | 0 - | 0 - | 5 5 patientsAge distribution💬 |
178 | Mowat-Wilson syndrome [Chr] 💬 | 0 - | 0 - | 0 - | 14 14 patientsAge distribution💬 |
180 | ATR-X syndrome [Chr] 💬 "Alpha-thalassemia mental retardation syndrome" | 1 1 trial | 0 / 1 / 0 / 0 💬 | 3 3 drugs [ 2 2 drugs ] | 0 - | 6 6 patientsAge distribution💬 |
185 | Coffin-Siris syndrome [Chr] 💬 | 0 - | 0 - | 0 - | 4 4 patientsAge distribution💬 |
186 | Rothmund-Thomson syndrome [Chr] 💬 "RAPADILINO syndrome", "Baller-Gerold syndrome" | 0 - | 0 - | 0 - | 3 3 patientsAge distribution💬 |
187 | Kabuki syndrome [Chr] 💬 | 4 4 trials | 1 / 0 / 0 / 0 💬 | 9 9 drugs [ 2 2 drugs ] | 2 2 genes 11 pathways | 19 19 patientsAge distribution💬 |
192 | Cockayne syndrome [Chr] 💬 "CS" | 4 4 trials | 1 / 3 / 0 / 0 💬 | 7 7 drugs [ 3 3 drugs ] | 1 1 gene 51 pathways | 6 6 patientsAge distribution💬 |
194 | Sotos syndrome [Chr] 💬 | 0 - | 0 - | 0 - | 23 23 patientsAge distribution💬 |
195 | Noonan syndrome [Chr] 💬 | 25 25 trials | 0 / 3 / 16 / 0 💬 | 23 23 drugs [ 5 5 drugs ] | 2 2 genes 9 pathways | 46 46 patientsAge distribution💬 |
196 | Young-Simpson syndrome [Chr] 💬 | 0 - | 0 - | 0 - | - |
197 | 1p36 deletion syndrome [Chr] 💬 | 0 - | 0 - | 0 - | 8 8 patientsAge distribution💬 |
198 | 4p deletion syndrome [Chr] 💬 "4p-syndrome" | 0 - | 0 - | 0 - | 8 8 patientsAge distribution💬 |
199 | 5p deletion syndrome [Chr] 💬 "5p-syndrome" | 0 - | 0 - | 0 - | 7 7 patientsAge distribution💬 |
200 | Paternal uniparental disomy of chromosome 14 [Chr] 💬 "No. 14 chromosome father disomy syndrome", "Kagami-Ogata syndrome" | 0 - | 0 - | 0 - | 6 6 patientsAge distribution💬 |
202 | Smith-Magenis syndrome [Chr] 💬 | 9 9 trials | 7 / 4 / 2 / 1 💬 | 10 10 drugs [ 5 5 drugs ] | 4 4 genes 7 pathways | 4 4 patientsAge distribution💬 |
204 | Emanuel syndrome [Chr] 💬 "Derivative 22 syndrome", "Partial trisomy (11", "22)" | 0 - | 0 - | 0 - | 5 5 patientsAge distribution💬 |
205 | Fragile X syndrome related disease [Chr] 💬 "Fragile X-associated tremor/ataxia syndrome", "FXTAS", "Fragile X-associated tremor", "Ataxia syndrome" | 5 5 trials | 0 / 2 / 1 / 0 💬 | 7 7 drugs [ 5 5 drugs ] | 22 22 genes 25 pathways | 8 8 patientsAge distribution💬 |
206 | Fragile X syndrome [Chr] 💬 | 108 108 trials | 35 / 49 / 16 / 8 💬 | 91 91 drugs [ 36 36 drugs ] | 52 52 genes 77 pathways | 1 1 patientAge distribution💬 |
227 | Osler disease [Chr] 💬 "Hereditary hemorrhagic telangiectasia", "Osler-Weber-Rendu disease" | 56 56 trials | 22 / 31 / 14 / 5 💬 | 72 72 drugs [ 21 21 drugs ] | 23 23 genes 136 pathways | 895 895 patientsAge distribution💬 |
287 | Epstein syndrome [Chr] 💬 | 0 - | 0 - | 0 - | 12 12 patientsAge distribution💬 |
310 | Congenital anomalies syndrome [Chr] 💬 "Partial trisomy 1q syndrome", "Trisomy 1q", "9q34 deletion syndrome", "Cornelia de Lange syndrome", "CdLS", "Smith-Lemli-Opitz syndrome", "SLO syndrome" | 11 11 trials | 2 / 7 / 0 / 0 💬 | 20 20 drugs [ 10 10 drugs ] | 3 3 genes 7 pathways | 32 32 patientsAge distribution💬 |
333 | Hutchinson-Gilford syndrome [Chr] 💬 "Hutchinson-Gilford progeria syndrome", "HGPS" | 8 8 trials | 2 / 5 / 0 / 0 💬 | 8 8 drugs [ 3 3 drugs ] | 4 4 genes 6 pathways | - |